Log In
BCIQ
Print this Print this
 

AAV-MTM1

  Manage Alerts
Collapse Summary General Information
Company Genethon
DescriptionRecombinant serotype 8 adeno-associated virus (AAV8) vector targeting myotubularin 1 (MTM1)
Molecular Target Myotubularin 1 (MTM1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat myotubular myopathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/14/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today